U.S. Markets close in 5 hrs 7 mins

Gene-editing stocks tumble on concerns about DNA damage

Emma Court

MARKET PULSE Shares of companies developing CRISPR gene-editing therapies dropped in Monday morning trade after a study found that the technique can damage DNA. The research, published in the peer-reviewed journal Nature Biotechology, is just the latest questioning whether the technique brings more benefit than harms to patients, with a report in June raising the possibility that edited cells could cause cancer.